ClinicalTrials.gg
Status unknownNCT05652166MICEUpdated Dec 15, 2022

What Information is Remembered by Parents Following the Ingestion of Foreign Body by Their Child?

An observational study in Information Remembered by Parents Following the Ingestion of Foreign Body by Their Child, sponsored by Assistance Publique - Hôpitaux de Paris. Status unknown at 1 site in France. Open to participants aged 0 Years to 18 Years. Per ClinicalTrials.gov, last updated 2022-12-15.

Sponsored by Assistance Publique - Hôpitaux de Paris · Observational

The sponsor has not verified this record recently (last verified Nov 2022), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
40
Ages
0 Years to 18 Years
Sex
All
01

Study summary

Foreign body (FB) ingestion is a very common domestic accident in children. The prevention of the recurrence by securing child's environment is mandatory. The study will study whether the advices of follow-up at home and recurrence prophylaxis were given to parents after a foreign ingestion by their child.

Read the detailed description

Foreign body ingestion (FB) is a very common domestic accident in children. When the FB is not dangerous or it is inaccessible after crossing the pylorus, the child should be monitored. In all cases, recurrence should be prevented by securing the environment of the swallowing child. The information on monitoring and securing the environment should be communicated during hospital care. This prospective study will analyze whether advices were correctly given to the families concerning the follow-up at home and the prophylaxis of FB ingestion.

02

Conditions studied

  • Information Remembered by Parents Following the Ingestion of Foreign Body by Their Child

Browse trials for

03

In context

Foreign Bodies

29 studies on the registry are indexed under Foreign Bodies; 8 are open to participants now.

This study's planned enrollment of 40 is below the median of 100 across 19 observational studies indexed under Foreign Bodies.

Browse Foreign Bodies studies →

Lead sponsor

Assistance Publique - Hôpitaux de Paris is the lead sponsor of 3,592 studies on the registry; 1,033 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
0 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Children consulting at Robert Debre Hospital following the ingestion of foreign body

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children under 18 years
  • Foreign body ingestion

Exclusion criteria

Exclusion Criteria:

  • Refusal to participate in the study
  • Non-French speaking parents
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
40 participants (estimated)
Patient registry
No

Interventions

  • Othertelephone interview

    telephone call to parents to know the information given following the ingestion of foreign body by their child

06

What researchers measure

Primary outcomes

  1. Identify the instructions memorized by the parents after a visit to the hospital for a foreign body ingestion by their child.

    Time frame: 1 year

07

Study locations

1 of 1 sites recruiting
  • Robert Debre Hospital
    Paris, 75019, France
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 15, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05652166
Responsible party
Sponsor
First posted
Dec 15, 2022
Start date
May 1, 2022
Primary completion
May 1, 2023 (estimated)
Completion
May 1, 2023 (estimated)
Last update
Dec 15, 2022

Study contacts

Jérôme VIALA, MD, PhD
Contact
jerome.viala@aphp.fr
+33140030000
Naim DRID, MD
Contact
naim.drid@aphp.fr
+33140030000
Jérôme VIALA, MD, PhD
principal investigator · Assistance Publique - Hôpitaux de Paris

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion